Health ❯ Vaccines

mRNA Vaccines

COVID-19 Vaccines Flu Vaccines Vaccine Development Research and Development Public Health Development Infectious Diseases Pandemic Preparedness COVID-19 Covid-19

Engineered mRNA Nanoparticles Reroute Delivery to Lymph Nodes in Mouse Study

The Penn design cuts liver exposure about tenfold to support lower-dose, better-tolerated mRNA vaccines.

FDA Reverses Course To Review Moderna’s mRNA Flu Shot Under Split Pathway

FDA Rejects Filing of Moderna’s mRNA Flu Vaccine Over Comparator Dispute

FDA Refuses to File Moderna’s mRNA Flu Vaccine Application Over Trial Comparator

FDA Rejects Moderna’s U.S. Filing for mRNA Flu Shot Over Trial Design

Study Pinpoints Immune Signals Behind Rare Myocarditis After mRNA COVID Vaccines

Pfizer’s mRNA Flu Shot Tops Standard Vaccine in Large Phase 3 Trial

Pfizer’s mRNA Flu Shot Shows 34.5% Higher Efficacy Than Standard Vaccine in Phase 3

mRNA Covid Vaccination Linked to Longer Survival When Given Near Cancer Immunotherapy, Nature Study Finds

mRNA COVID Vaccination Linked to Longer Survival With Cancer Immunotherapy, Data Presented at ESMO

Moderna Opens UK’s First Onshore mRNA Vaccine Plant at Harwell

Pfizer Releases Multi-Study Findings on Myocarditis Risk After Its Covid Vaccine

Lipid Nanoparticle Cargo, Not the Shell, Drives Dendritic Cell Fate, Belgian Study Finds

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings

US Cuts $500 Million in mRNA Vaccine Research Funding

HHS Cancels $500M in mRNA Vaccine Contracts, Winding Down Respiratory Virus Efforts

RFK Jr. Terminates $500 Million in BARDA mRNA Vaccine Projects as Experts Warn of Consequences

HHS Withdraws $500 Million for mRNA Vaccine Research as Experts Warn of Pandemic Risks

Kennedy Halts $500 Million in mRNA Vaccine Contracts, Shifts Investment to Alternative Platforms

Kennedy Slashes $500 Million From mRNA Respiratory Vaccine Programs